Transplantation, AutologousMultiple MyelomaTransplantation, HomologousHematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation ConditioningLiver TransplantationStem Cell TransplantationGraft vs Host DiseaseMelphalanKidney TransplantationGraft SurvivalPeripheral Blood Stem Cell TransplantationTreatment OutcomeHematopoietic Stem Cell MobilizationTransplantation ChimeraHematologic NeoplasmsRecurrenceTissue DonorsHeart TransplantationRemission InductionCombined Modality TherapyGraft vs Tumor EffectLung TransplantationSalvage TherapyWhole-Body IrradiationThalidomideTransplantation, IsogeneicAntigens, CD34Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsSurvival AnalysisGranulocyte Colony-Stimulating FactorGraft RejectionBusulfanTransplantation ImmunologyImmunosuppressive AgentsLymphoma, Non-HodgkinRetrospective StudiesMyeloablative AgonistsLeukapheresisSurvival RateCyclophosphamideHematopoietic Stem CellsDisease-Free SurvivalBoronic AcidsBlood Transfusion, AutologousPyrazinesBlood Component RemovalMyeloma ProteinsOrgan TransplantationTime FactorsLeukemiaBone Marrow PurgingHistocompatibility TestingIslets of Langerhans TransplantationCarmustineBone MarrowPancreas TransplantationFollow-Up StudiesCord Blood Stem Cell TransplantationLeukemia, Myeloid, AcuteTransplantationHodgkin DiseaseHistocompatibilityBone Marrow CellsPlasma CellsPrognosisAntineoplastic AgentsImmunosuppressionT-LymphocytesDexamethasoneNeoplasm, ResidualLymphomaMyelodysplastic SyndromesVidarabineGraft vs Leukemia EffectAcute DiseaseEtoposideCyclosporineParaproteinemiasLymphocyte DepletionImmunomagnetic SeparationTransplantation, HeterotopicAntibodies, MonoclonalLiving DonorsPrecursor Cell Lymphoblastic Leukemia-LymphomaCell SeparationVincristineCytarabineHLA AntigensSkin TransplantationLymphocyte TransfusionTransplantation TolerancePrednisoneAllograftsAntigens, CDCells, CulturedHeart-Lung TransplantationProspective Studies